MMA Embolization for Chronic Subdural Hematoma: Advancing Minimally Invasive Neurointervention
Amit Bhatti, Consultant Interventional Neurologist at Wockhardt hospital Nagpur, posted on LinkedIn:
” I had the privilege of presenting our clinical experience with Middle Meningeal Artery (MMA) Embolization for Chronic Subdural Hematoma (CSDH) at the Maharashtra Association of Neurologists Conference.
I’m humbled that our work – and the outcomes we’ve been able to achieve for patients – was so warmly appreciated by peers and senior colleagues across the state.
CSDH remains a challenging condition, particularly in elderly and high-risk patients, and MMA embolization is emerging as a powerful, minimally invasive treatment option. Our series reinforces what global literature has increasingly shown –
– Reduced recurrence
– Fewer reoperations
– Faster recovery
– Improved quality of life
What makes this journey meaningful is not just the scientific progress but the impact it creates in restoring independence, dignity, and hope for patients and families.
Grateful to the organizing team of MAN Conference for the opportunity, to my mentors and colleagues for their constant support, and to my patients who place their trust in us every single day.
Excited to continue contributing to innovation in neurointervention and advancing stroke & brain health care in India.”
Stay updated with Hemostasis Today.
-
Sep 3, 2026, 01:19Himanshu Aggarwal: 1 mg/kg/d Thalidomide Non-Inferior to Standard Dose in Transfusion-Dependent Thalassemia
-
Sep 3, 2026, 01:03SHOT Urges Safe Component Matching While NHSBT Appeals for Black Donors
-
Sep 3, 2026, 00:52David Wallace: FDA Approves MIMRYLO to Target Iron Regulation and Reduce Phlebotomy Burden
-
Sep 3, 2026, 00:44Same goal, Different molecular strategy – Which FVIIIa Mimetic Gets There How? – RPTH Journal
-
Sep 3, 2026, 00:33Hannah Isles: Interesting Link between Aging, Serotonin, Platelets and COVID-19 Severity
-
Sep 3, 2026, 00:22Danny Hsu: Paradigm Shift in PE Management? – Unpacking the PRAGUE-26 Trial
-
Sep 3, 2026, 00:14Leonardo Roever: Antiphospholipid Antibodies Present in 19% of Ischemic Stroke Cases
-
Sep 3, 2026, 00:03Jochebed Adwoa Sutherland: First Reported Case of Breast Mondor’s Disease in a Patient Living with Sickle Cell
-
Sep 2, 2026, 23:50Shashank Joshi: Individualized vs. Standard BP Control Shows Similar 90-Day Outcomes